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Résumé en
anglais
Acute myeloid leukemia (AML) with t(8;21) and inv(16), together referred as core
binding factor (CBF)-AML, are recognized as unique entities. Both rearrangements
share a common pathophysiology, the disruption of the CBF, and a relatively good
prognosis. Experiments have demonstrated that CBF rearrangements were insufficient
to induce leukemia, implying the existence of cooperating events. To explore these
aberrations, we performed single nucleotide polymorphism (SNP)-array in a well-
annotated cohort of 198 patients with CBF-AML. Excluding breakpoint-associated
lesions, the most frequent events included loss of a sex chromosome (53%), deletions
at 9q21 (12%) and 7q36 (9%) in patients with t(8;21) compared with trisomy 22 (13%),
trisomy 8 (10%) and 7q36 deletions (12%) in patients with inv(16). SNP-array revealed
novel recurrent genetic alterations likely to be involved in CBF-AML leukemogenesis.
mutations (20% of t(8;21)-AML) were shown to be a target of copy-neutral losses of
heterozygosity (CN-LOH) at chromosome 19p. focal deletions were identified in 5% of
inv(16)-AML while sequence analysis revealed that 2% carried truncating mutations.
Finally, disruption was found in both subtypes (4.5% of the whole cohort) and possibly
highlighted a new lesion associated with aberrant tyrosine kinase signaling in this
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